SUMIMASA ARIMURA to Humans
This is a "connection" page, showing publications SUMIMASA ARIMURA has written about Humans.
Connection Strength
0.062
-
Changing Fate: How EGFRs "Pit" Cell Versus Cell in the Stomach. Gastroenterology. 2024 08; 167(3):441-442.
Score: 0.023
-
Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction. Science. 2014 Sep 19; 345(6203):1505-8.
Score: 0.012
-
Reduced level of smoothened suppresses intestinal tumorigenesis by down-regulation of Wnt signaling. Gastroenterology. 2009 Aug; 137(2):629-38.
Score: 0.008
-
Metabolic regulator ERR? governs gastric stem cell differentiation into acid-secreting parietal cells. Cell Stem Cell. 2024 06 06; 31(6):886-903.e8.
Score: 0.006
-
Functional characterization of age-dependent p16 epimutation reveals biological drivers and therapeutic targets for colorectal cancer. J Exp Clin Cancer Res. 2023 May 04; 42(1):113.
Score: 0.005
-
Drivers of transcriptional variance in human intestinal epithelial organoids. Physiol Genomics. 2021 11 01; 53(11):486-508.
Score: 0.005
-
DOK7 gene therapy enhances motor activity and life span in ALS model mice. EMBO Mol Med. 2017 07; 9(7):880-889.
Score: 0.004